Eagle Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $443k | 79k | 5.60 |
| 2024-03-31 | $932k | 178k | 5.24 |
| 2023-12-31 | $1.0M | 194k | 5.23 |
| 2023-09-30 | $2.5M | 161k | 15.77 |
| 2023-06-30 | $4.2M | 215k | 19.44 |
| 2023-03-31 | $4.8M | 170k | 28.37 |
| 2022-12-31 | $4.1M | 142k | 29.23 |
| 2022-06-30 | $7.4M | 166k | 44.43 |
| 2022-03-31 | $8.8M | 178k | 49.50 |
| 2021-12-31 | $5.5M | 108k | 50.93 |
| 2021-09-30 | $6.0M | 107k | 55.77 |
| 2021-03-31 | $5.7M | 137k | 41.74 |
| 2020-12-31 | $6.9M | 148k | 46.56 |
| 2020-09-30 | $7.1M | 167k | 42.48 |
| 2020-06-30 | $5.8M | 121k | 47.98 |
| 2019-12-31 | $8.3M | 138k | 60.08 |
| 2019-09-30 | $3.8M | 68k | 56.57 |
| 2019-06-30 | $5.9M | 106k | 55.68 |
| 2019-03-31 | $6.6M | 131k | 50.49 |
| 2018-12-31 | $6.5M | 163k | 40.29 |
| 2018-09-30 | $12M | 168k | 69.33 |
| 2018-06-30 | $9.1M | 120k | 75.66 |
| 2018-03-31 | $5.4M | 102k | 52.69 |
| 2017-12-31 | $5.9M | 111k | 53.42 |
| 2017-09-30 | $5.3M | 89k | 59.64 |
| 2017-06-30 | $8.6M | 110k | 78.89 |
| 2017-03-31 | $13M | 154k | 82.94 |
| 2016-12-31 | $3.5M | 44k | 79.35 |
| 2016-09-30 | $2.2M | 31k | 69.99 |
| 2016-06-30 | $1.1M | 28k | 38.79 |
| 2016-03-31 | $4.6M | 113k | 40.50 |
| 2015-12-31 | $6.2M | 70k | 88.72 |
| 2015-09-30 | $507k | 6.8k | 74.22 |
| 2015-06-30 | $1.5M | 18k | 80.84 |
| 2015-03-31 | $412k | 9.8k | 41.87 |